arXiv:2608. 12219v1 Announce Type: new Abstract: Treating patients with combinations of drugs reduces the risk of resistance to any individual drug.
By Antoine de Mathelin, Christopher Tosh, Wesley Tansey
The paper introduces AssayBench-Loop, a large benchmark of 1,389 CRISPR screens across five phenotype categories, and builds on it to develop AssayLoop, a sequential experimental design framework that combines a transformer-based acquisition policy (AssayFormer) trained on historical data with LLM-derived biological priors. AssayLoop achieves a 5.67‑fold enrichment over random selection, recovering 27.7% of hits after testing only about 5% of the library, and outperforms existing adaptive-design methods and standalone LLMs. The authors also present AssayLLM, extending the approach directly to an LLM via task‑specific post‑training, and show that performance improves with more historical training data and transfers to unseen phenotype categories.
By Carl Edwards, Edward De Brouwer, Xiner Li, Namkyeong Lee, Ehsan Hajiramezanali, Anne Biton, Sara Mostafavi, Gabriele Scalia
arXiv:2608. 03606v1 Announce Type: new Abstract: Clinical development is sequential decision-making under uncertainty, where a sponsor must plan a portfolio of experiments from heterogeneous evidence.
By William Bolton, Philip Torr
arXiv:2610.07045v1 Announce Type: cross
Abstract: Many scientific studies allow costly auxiliary information to be collected during data labeling but not at deployment. Examples include diagnostic te...
By Hanwen Ye, Jiuchen Zhang, Annie Qu
PerturbRx is a treatment‑conditioned representation learning framework that learns latent transitions induced by drug interventions. It trains a drug‑ and dose‑conditioned transition predictor using control and treated single‑cell populations, then applies this predictor to pretreatment patient profiles to generate response features without needing post‑treatment data. On TCGA and patient‑derived xenograft benchmarks, PerturbRx outperforms other methods, demonstrating the value of perturbation‑pretrained latent transitions for patient‑level drug‑response prediction.
By Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna
arXiv:2608. 19906v1 Announce Type: new Abstract: Accurately ranking active ligands for a target protein pocket from massive chemical libraries remains a central challenge in virtual screening.
By Jia-Qi Lin, Yinghua Yao, Chang-Dong Wang, Yew-Soon Ong, Yuangang Pan